Source: Annual Congress 2001 - Basic mechanisms of lung injury
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Haider, M. W. Ferguson, J. J. Egan (Manchester, United Kingdom; Dublin, Ireland). The effect of bleomycin on the lungs of TGFβ1 transgenic mice. Eur Respir J 2001; 16: Suppl. 31, 599

Member's Comments

No comment yet.

Related content which might interest you: Expression of α-1-antitrypsin after intraperitoneal and intratracheal lipopolysaccharide in wild-type C57BL/6 mice Source: Eur Respir J 2004; 24: Suppl. 48, 102s Year: 2004 The effect of GM-CSF on lung maturation and parenchymal NOS expression in prenatally treated Balb/c mice Source: Eur Respir J 2005; 26: Suppl. 49, 341s Year: 2005 Allergen-induced inflammation and airway responsiveness in a mouse model of asthma: comparison between C57BL/6 and Th2-prone BALB/c mice Source: Eur Respir J 2003; 22: Suppl. 45, 484s Year: 2003 Effects of exercise on lung inflammation in ovalbumin-sensitized and single challenged mice Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012 Vascular remodeling in the lung from mice treated with monocrotaline. The effect of protein C inhibitor transgenic expression Source: Eur Respir J 2006; 28: Suppl. 50, 823s Year: 2006 Effects of swimming on lung inflammation in ovalbumin-sensitized and challenged mice Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012 Enhanced lung fibrosis in protein C inhibitor transgenic mice Source: Eur Respir J 2004; 24: Suppl. 48, 481s Year: 2004 Increased susceptibility to gammaherpesvirus-induced lung fibrosis of transgenic mice with conditional overexpression of the ER-stress-factor Chop in alveolar epithelium Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Precision cut lung slices from bleomycin challenged mice – ex vivo model for testing novel therapies for lung fibrosis Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Disruption of Nrf2 enhances susceptibility to pulmonary fibrosis induced by bleomycin in mice Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 BALB/c mice develop lung fibrosis after six months of cigarette smoke-exposure Source: Eur Respir J 2004; 24: Suppl. 48, 252s Year: 2004 Lung tumor growth quantification in transgenic mice using μCT and μPET Source: Annual Congress 2008 - Imaging of different lung diseases: clinical and experimental observations Year: 2008 Effect of Nintedanib in a rat model of lung fibrosis induced by single or double bleomycin administration Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017 Tenascin C knockout mice have an altered lung function at newborn and adult age Source: International Congress 2017 – Molecular pathways in lung development Year: 2017 Effect of administration of purified fish oil on bleomycin induced lung fibrosis in rats Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Alteration of eicosanoid metabolism/signalling in IL-9 overexpressing mice and impact on lung fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 575s Year: 2007 Premature aging in Zmpste24 deficient mice protects them from bleomycin induced lung fibrosis through upregulation of antifibrotic microRNAs Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018 Transgenic mice expressing a surfactant protein-B-urokinase-fusion protein in the distal respiratory epithelium show an attenuated fibrotic response to bleomycin-induced lung injury Source: Annual Congress 2005 - In vivo - approaches to lung injury Year: 2005 Dose-dependent effects of muIL-13Rα2, a potent IL-13 neutraliser, on the phenotype of an acute allergic airways inflammation model in BALB/c mice Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology Year: 2004